D. E. Shaw & Co., Inc. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$12,000
-20.0%
16,4970.0%0.00%
Q1 2020$15,000
-94.6%
16,497
-87.9%
0.00%
Q4 2019$278,000
-37.1%
136,141
-11.6%
0.00%
-100.0%
Q3 2019$442,000
-83.6%
154,053
-56.1%
0.00%
-66.7%
Q2 2019$2,690,000
+11.3%
350,694
+92.8%
0.00%0.0%
Q1 2019$2,417,000
-37.9%
181,862
-27.2%
0.00%
-40.0%
Q4 2018$3,890,000
-49.8%
249,718
-36.6%
0.01%
-44.4%
Q3 2018$7,745,000
-52.3%
394,137
-30.4%
0.01%
-57.1%
Q2 2018$16,241,000
+85.5%
565,884
+52.9%
0.02%
+75.0%
Q1 2018$8,754,000
-28.6%
370,173
-35.3%
0.01%
-29.4%
Q4 2017$12,265,000
-8.0%
571,767
+1.4%
0.02%
-15.0%
Q3 2017$13,336,000
+9.4%
563,913
-8.9%
0.02%0.0%
Q2 2017$12,190,000
+31.4%
618,760
+40.1%
0.02%
+25.0%
Q1 2017$9,274,000
-28.9%
441,624
-36.3%
0.02%
-27.3%
Q4 2016$13,037,000
-6.8%
693,468
+3.6%
0.02%
-12.0%
Q3 2016$13,983,000
+0.1%
669,689
+22.2%
0.02%
-3.8%
Q2 2016$13,972,000
-3.2%
547,815
+0.4%
0.03%0.0%
Q1 2016$14,430,000
+96.2%
545,551
+217.3%
0.03%
+136.4%
Q4 2015$7,355,000
+826.3%
171,921
+474.3%
0.01%
+1000.0%
Q3 2015$794,000
+143.6%
29,938
+205.7%
0.00%
Q2 2015$326,000
-59.9%
9,794
-59.9%
0.00%
-100.0%
Q1 2015$813,000
-15.2%
24,428
+4.1%
0.00%0.0%
Q4 2014$959,000
-57.3%
23,469
-64.6%
0.00%
-66.7%
Q3 2014$2,247,000
+510.6%
66,333
+426.5%
0.00%
+200.0%
Q4 2013$368,00012,6000.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders